Dong‐Ning Chen

432 total citations
35 papers, 276 citations indexed

About

Dong‐Ning Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Dong‐Ning Chen has authored 35 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Dong‐Ning Chen's work include Prostate Cancer Treatment and Research (12 papers), Ferroptosis and cancer prognosis (8 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Dong‐Ning Chen is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Ferroptosis and cancer prognosis (8 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Dong‐Ning Chen collaborates with scholars based in China, Hong Kong and Malaysia. Dong‐Ning Chen's co-authors include Ning Xu, Xue‐Yi Xue, Qing‐Shui Zheng, Yong Wei, Yu‐Peng Wu, Jin‐Kui Yang, Jing Cui, Zhi‐Bin Ke, Shao‐Hao Chen and Xin Zhong and has published in prestigious journals such as The Science of The Total Environment, Environmental Pollution and International Journal of Molecular Sciences.

In The Last Decade

Dong‐Ning Chen

34 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Ning Chen China 9 95 86 80 55 38 35 276
Arbil Açıkalın Türkiye 12 87 0.9× 53 0.6× 70 0.9× 14 0.3× 31 0.8× 49 344
Chi‐Juei Jeng Taiwan 11 140 1.5× 48 0.6× 82 1.0× 87 1.6× 101 2.7× 15 371
Zijian Tian China 10 75 0.8× 81 0.9× 43 0.5× 14 0.3× 10 0.3× 33 244
Jing Hang China 10 47 0.5× 55 0.6× 62 0.8× 177 3.2× 7 0.2× 21 323
Ya Yang China 11 42 0.4× 94 1.1× 36 0.5× 56 1.0× 15 0.4× 51 359
John H. Lillvis United States 11 75 0.8× 195 2.3× 32 0.4× 28 0.5× 28 0.7× 18 334
Chenzhe Feng China 10 75 0.8× 63 0.7× 55 0.7× 26 0.5× 6 0.2× 20 279
Neha Varshney United States 6 85 0.9× 115 1.3× 84 1.1× 8 0.1× 6 0.2× 29 239

Countries citing papers authored by Dong‐Ning Chen

Since Specialization
Citations

This map shows the geographic impact of Dong‐Ning Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Ning Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Ning Chen more than expected).

Fields of papers citing papers by Dong‐Ning Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Ning Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Ning Chen. The network helps show where Dong‐Ning Chen may publish in the future.

Co-authorship network of co-authors of Dong‐Ning Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Ning Chen. A scholar is included among the top collaborators of Dong‐Ning Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Ning Chen. Dong‐Ning Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ke, Zhi‐Bin, Jia‐Yin Chen, Bin Lin, et al.. (2025). Mechanical signal modulates prostate cancer immune escape by USP8-mediated ubiquitination-dependent degradation of PD-L1 and MHC-1. Cell Death and Disease. 16(1). 413–413. 3 indexed citations
3.
Wang, Zhen, Dong‐Ning Chen, Junming Zhu, et al.. (2024). Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer. International Immunopharmacology. 138. 112623–112623. 3 indexed citations
4.
Lin, Fei, Zhi‐Bin Ke, Dong‐Ning Chen, et al.. (2024). A comprehensive analysis-based study of Di-(2-ethylhexyl) phthalate (DEHP)—Environmental explanation of bladder cancer progression. Environmental Pollution. 367. 125625–125625. 1 indexed citations
6.
Kang, Zhen, Dong‐Ning Chen, Qing‐Shui Zheng, et al.. (2024). Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning. Cancer Immunology Immunotherapy. 73(3). 41–41. 5 indexed citations
7.
Kang, Zhen, et al.. (2024). Disulfidptosis-related subtype and prognostic signature in prostate cancer. Biology Direct. 19(1). 97–97. 5 indexed citations
8.
Chiu, Peter Ka‐Fung, Ignacio Puche‐Sanz, Xue Zhao, et al.. (2024). Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study. Frontiers in Oncology. 14. 1321522–1321522. 2 indexed citations
10.
Chen, Hang, Jia‐Yin Chen, Shao‐Hao Chen, et al.. (2023). Exploring Novel Genome Instability-associated lncRNAs and theirPotential Function in Pan-Renal Cell Carcinoma. Combinatorial Chemistry & High Throughput Screening. 27(12). 1788–1807. 1 indexed citations
11.
Chen, Jia‐Yin, Fei Lin, Qi You, et al.. (2023). A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer. Genomics. 115(5). 110691–110691. 2 indexed citations
12.
Kang, Zhen, Fei Lin, Qi Huang, et al.. (2023). Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer. Frontiers in Oncology. 13. 1160972–1160972. 6 indexed citations
13.
Ke, Zhi‐Bin, Qi You, Xiaodong Li, et al.. (2022). A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer. Frontiers in Cell and Developmental Biology. 9. 774625–774625. 16 indexed citations
14.
Chen, Shao‐Hao, Zhi‐Bin Ke, Yu‐Peng Wu, et al.. (2020). <p>Predictors of Prolonged Laparoscopic Radical Prostatectomy and the Creation of a Scoring System for the Duration</p>. Cancer Management and Research. Volume 12. 8005–8014. 2 indexed citations
15.
Wu, Yu‐Peng, Xiaodan Lin, Shao‐Hao Chen, et al.. (2020). Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis. Frontiers in Genetics. 11. 892–892. 19 indexed citations
16.
Lin, Yun‐Zhi, Yu‐Peng Wu, Tingting Lin, et al.. (2019). Penoscrotal edema: a case report and literature review. BMC Urology. 19(1). 22–22. 5 indexed citations
18.
Xu, Ning, Yu‐Peng Wu, Dong‐Ning Chen, et al.. (2018). Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4–10 ng/ml?. Journal of Cancer Research and Clinical Oncology. 144(5). 987–995. 21 indexed citations
19.
Cui, Jing, Dong‐Ning Chen, Xin Zhong, et al.. (2017). Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study. BMJ Open. 7(8). e015473–e015473. 47 indexed citations
20.
Tao, Lixin, Xia Li, Huiping Zhu, et al.. (2013). Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study. Endocrine. 46(3). 485–495. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026